单针从9988元骤降至2790元,近2000元的降脂针“腰斩再腰斩”至300元级!长效降脂针医保落地至今早已满三个月,这场颠覆性的价格变革,让曾经的“天价救命针”变身“亲民药”,诺华、安进、信达生物等中外药企争相入局,咨询量、备货量迎来爆发式激增,千亿美元降脂赛道瞬间沸腾,一场没有硝烟的市场洗牌正激烈上演。 “我能不能打长效降脂针?”《华夏时报》记者从北京几家三甲医院了解到,今年以来,医院心血管...
Source Link单针从9988元骤降至2790元,近2000元的降脂针“腰斩再腰斩”至300元级!长效降脂针医保落地至今早已满三个月,这场颠覆性的价格变革,让曾经的“天价救命针”变身“亲民药”,诺华、安进、信达生物等中外药企争相入局,咨询量、备货量迎来爆发式激增,千亿美元降脂赛道瞬间沸腾,一场没有硝烟的市场洗牌正激烈上演。 “我能不能打长效降脂针?”《华夏时报》记者从北京几家三甲医院了解到,今年以来,医院心血管...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.